Cheryl Ho

3.6k total citations
145 papers, 1.9k citations indexed

About

Cheryl Ho is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cheryl Ho has authored 145 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 85 papers in Pulmonary and Respiratory Medicine and 24 papers in Cancer Research. Recurrent topics in Cheryl Ho's work include Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (32 papers). Cheryl Ho is often cited by papers focused on Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (32 papers). Cheryl Ho collaborates with scholars based in Canada, United States and United Kingdom. Cheryl Ho's co-authors include Janessa Laskin, Bonnie Leung, Barbara Melosky, Angela M. Davies, Nevin Murray, Alan Bates, David R. Gandara, Jonn Wu, Primo N. Lara and Natasha B. Leighl and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Cheryl Ho

135 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Cheryl Ho 1.1k 1.0k 411 227 166 145 1.9k
Paul Wheatley‐Price 1.1k 1.0× 978 1.0× 385 0.9× 309 1.4× 257 1.5× 133 2.0k
Victoria J. Sinibaldi 843 0.8× 1.1k 1.1× 535 1.3× 339 1.5× 156 0.9× 57 2.0k
Αngelos Koutras 1.6k 1.5× 543 0.5× 588 1.4× 390 1.7× 175 1.1× 132 2.5k
Charles C. Williams 1.0k 0.9× 925 0.9× 662 1.6× 201 0.9× 114 0.7× 83 2.1k
Gun Min Kim 785 0.7× 549 0.5× 260 0.6× 351 1.5× 221 1.3× 91 1.3k
Xavier Quantin 981 0.9× 766 0.8× 394 1.0× 234 1.0× 96 0.6× 115 1.9k
Kevin Kalinsky 1.1k 1.0× 558 0.6× 581 1.4× 506 2.2× 154 0.9× 107 1.9k
Phuong K. Morrow 1.0k 0.9× 396 0.4× 525 1.3× 283 1.2× 112 0.7× 65 1.8k
Maria Rita Migliorino 1.6k 1.4× 1.8k 1.8× 511 1.2× 330 1.5× 143 0.9× 40 2.3k
Gamini S. Soori 1.6k 1.5× 642 0.6× 428 1.0× 387 1.7× 332 2.0× 70 2.6k

Countries citing papers authored by Cheryl Ho

Since Specialization
Citations

This map shows the geographic impact of Cheryl Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Ho more than expected).

Fields of papers citing papers by Cheryl Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Ho. The network helps show where Cheryl Ho may publish in the future.

Co-authorship network of co-authors of Cheryl Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Ho. A scholar is included among the top collaborators of Cheryl Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Ho. Cheryl Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salmanpour, Mohammad R., et al.. (2025). Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets. Cancers. 17(2). 285–285. 2 indexed citations
2.
3.
Krebs, Emanuel, Deirdre Weymann, Cheryl Ho, et al.. (2025). Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation. JCO Precision Oncology. 9(9). e2400631–e2400631. 1 indexed citations
4.
Titmuss, Emma, Robert J. Vanner, David F. Schaeffer, et al.. (2024). Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors. Cancer Research Communications. 5(1). 66–73. 2 indexed citations
5.
6.
Mete, Özgür, Andrée Boucher, Kasmintan A. Schrader, et al.. (2024). Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocrine Pathology. 35(4). 293–308. 16 indexed citations
7.
8.
Titmuss, Emma, James T. Topham, David F. Schaeffer, et al.. (2024). Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.. Journal of Clinical Oncology. 42(3_suppl). 169–169.
9.
Xin, Xiaohui, et al.. (2023). The perceptions and adoption of environmentally sustainable practices among anesthesiologists—a qualitative study. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 70(3). 313–326. 11 indexed citations
10.
Anagnostou, Valsamo, Cheryl Ho, Garth Nicholas, et al.. (2023). ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nature Medicine. 29(10). 2559–2569. 66 indexed citations
11.
Li, Kelly, Ian Bosdet, Stephen Yip, et al.. (2023). Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Current Oncology. 30(8). 7099–7111. 1 indexed citations
12.
13.
Leung, Bonnie, Mitchell Liu, Eric Berthelet, et al.. (2023). Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression. Current Oncology. 30(8). 7499–7507. 7 indexed citations
14.
Yip, Stephen, Barbara Melosky, Cheryl Ho, et al.. (2022). Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current Oncology. 30(1). 145–156. 2 indexed citations
15.
Titmuss, Emma, Alexandra Pender, James T. Topham, et al.. (2022). The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space. Journal of Molecular Diagnostics. 24(6). 609–618. 7 indexed citations
16.
Alex, Deepu, Ian Bosdet, Curtis Hughesman, et al.. (2021). MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy. Lung Cancer. 154. 142–145. 17 indexed citations
17.
Dudani, Shaan, Xiaofu Zhu, Daniel Yokom, et al.. (2017). Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes. Clinical Lung Cancer. 19(1). e11–e18. 4 indexed citations
18.
Yan, Michael, Cheryl Ho, Eric Winquist, et al.. (2016). Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic Acid. Clinical Colorectal Cancer. 15(4). 369–376.e3. 7 indexed citations
19.
Dudani, Shaan, Natasha B. Leighl, Cheryl Ho, et al.. (2016). Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists. Lung Cancer. 94. 74–80. 7 indexed citations
20.
Noonan, Krista, Janessa Laskin, Yulong Zheng, et al.. (2015). Evaluation of a ‘Watch and Wait’ Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population. Clinical Oncology. 27(9). 505–513. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Wheatley‐Price Breakdown of academic impact, for papers by Victoria J. Sinibaldi Breakdown of academic impact, for papers by Αngelos Koutras Breakdown of academic impact, for papers by Charles C. Williams Breakdown of academic impact, for papers by Gun Min Kim Breakdown of academic impact, for papers by Xavier Quantin Breakdown of academic impact, for papers by Kevin Kalinsky Breakdown of academic impact, for papers by Phuong K. Morrow Breakdown of academic impact, for papers by Maria Rita Migliorino Breakdown of academic impact, for papers by Gamini S. Soori
Rankless by CCL
2026